Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.61852846 |
2 | negative regulation of interleukin-12 production (GO:0032695) | 4.24753515 |
3 | response to peptidoglycan (GO:0032494) | 4.18439477 |
4 | regulation of vitamin metabolic process (GO:0030656) | 3.77095096 |
5 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.53419435 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 3.51999513 |
7 | modulation by symbiont of host defense response (GO:0052031) | 3.51999513 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.51999513 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.51999513 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.51999513 |
11 | modulation by symbiont of host immune response (GO:0052553) | 3.51999513 |
12 | regulation of podosome assembly (GO:0071801) | 3.51854856 |
13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.51212784 |
14 | germinal center formation (GO:0002467) | 3.44846144 |
15 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.39973283 |
16 | positive regulation of heat generation (GO:0031652) | 3.35426947 |
17 | regulation of fever generation (GO:0031620) | 3.32330296 |
18 | positive regulation of interferon-alpha production (GO:0032727) | 3.31130751 |
19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30417649 |
20 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30357255 |
21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.28379934 |
22 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.21365299 |
23 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.20754645 |
24 | T-helper 1 type immune response (GO:0042088) | 3.19940331 |
25 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.19725697 |
26 | NIK/NF-kappaB signaling (GO:0038061) | 3.19681493 |
27 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.19471128 |
28 | negative regulation of cell killing (GO:0031342) | 3.15647782 |
29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.15647782 |
30 | macrophage activation involved in immune response (GO:0002281) | 3.15445057 |
31 | protein localization to endosome (GO:0036010) | 3.13425888 |
32 | neutrophil activation involved in immune response (GO:0002283) | 3.11898829 |
33 | regulation of interferon-alpha production (GO:0032647) | 3.11809850 |
34 | low-density lipoprotein particle clearance (GO:0034383) | 3.08427608 |
35 | sodium ion export (GO:0071436) | 3.05178704 |
36 | response to muramyl dipeptide (GO:0032495) | 3.05106014 |
37 | myeloid dendritic cell differentiation (GO:0043011) | 3.03776991 |
38 | macroautophagy (GO:0016236) | 2.95808123 |
39 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.95659344 |
40 | response to protozoan (GO:0001562) | 2.93751004 |
41 | glycosphingolipid catabolic process (GO:0046479) | 2.93644915 |
42 | detection of molecule of bacterial origin (GO:0032490) | 2.92648384 |
43 | regulation of cholesterol storage (GO:0010885) | 2.89196665 |
44 | oligosaccharide catabolic process (GO:0009313) | 2.88819600 |
45 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86939795 |
46 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.85236373 |
47 | regulation of chronic inflammatory response (GO:0002676) | 2.84226039 |
48 | defense response to protozoan (GO:0042832) | 2.83712266 |
49 | regulation of necroptotic process (GO:0060544) | 2.83106430 |
50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80990014 |
51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.80433220 |
52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.80433220 |
53 | regulation of mononuclear cell migration (GO:0071675) | 2.79359958 |
54 | NLS-bearing protein import into nucleus (GO:0006607) | 2.79308010 |
55 | regulation of chemokine biosynthetic process (GO:0045073) | 2.79288933 |
56 | growth hormone receptor signaling pathway (GO:0060396) | 2.77532275 |
57 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77335587 |
58 | regulation of ARF protein signal transduction (GO:0032012) | 2.77018693 |
59 | negative regulation of lipid storage (GO:0010888) | 2.75028852 |
60 | cell adhesion mediated by integrin (GO:0033627) | 2.73720796 |
61 | myeloid dendritic cell activation (GO:0001773) | 2.70733785 |
62 | positive regulation of histone deacetylation (GO:0031065) | 2.70562483 |
63 | I-kappaB phosphorylation (GO:0007252) | 2.69198124 |
64 | cellular response to ethanol (GO:0071361) | 2.68074908 |
65 | response to thyroid hormone (GO:0097066) | 2.68009442 |
66 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.67620449 |
67 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.66920239 |
68 | cellular response to lipopolysaccharide (GO:0071222) | 2.65634483 |
69 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.64930796 |
70 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.64353300 |
71 | glycolipid catabolic process (GO:0019377) | 2.63537376 |
72 | cellular response to arsenic-containing substance (GO:0071243) | 2.63257750 |
73 | positive regulation of type 2 immune response (GO:0002830) | 2.62371590 |
74 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.61132775 |
75 | positive regulation of p38MAPK cascade (GO:1900745) | 2.60684792 |
76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.60548091 |
77 | regulation of cholesterol homeostasis (GO:2000188) | 2.60197229 |
78 | cellular response to molecule of bacterial origin (GO:0071219) | 2.59008039 |
79 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.58102906 |
80 | granulocyte activation (GO:0036230) | 2.57946367 |
81 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57611134 |
82 | synaptic vesicle maturation (GO:0016188) | 2.57163685 |
83 | modulation by symbiont of host cellular process (GO:0044068) | 2.56850807 |
84 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.56004591 |
85 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.55892650 |
86 | lipoprotein transport (GO:0042953) | 2.55053073 |
87 | regulation of response to interferon-gamma (GO:0060330) | 2.54705457 |
88 | macrophage activation (GO:0042116) | 2.54362620 |
89 | apoptotic cell clearance (GO:0043277) | 2.53469348 |
90 | monocyte chemotaxis (GO:0002548) | 2.53193057 |
91 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.51645198 |
92 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.51595985 |
93 | positive regulation of interleukin-6 production (GO:0032755) | 2.50524500 |
94 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.50432108 |
95 | stress fiber assembly (GO:0043149) | 2.49468472 |
96 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.49386988 |
97 | regulation of interleukin-12 production (GO:0032655) | 2.48813477 |
98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.48666339 |
99 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.47772943 |
100 | cellular extravasation (GO:0045123) | 2.46905004 |
101 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.46102978 |
102 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.45180519 |
103 | proline transport (GO:0015824) | 2.44102577 |
104 | ovulation (GO:0030728) | 2.42751263 |
105 | activation of MAPKKK activity (GO:0000185) | 2.42728769 |
106 | cellular potassium ion homeostasis (GO:0030007) | 2.40683342 |
107 | response to host immune response (GO:0052572) | 2.39717957 |
108 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.39717957 |
109 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.39128900 |
110 | embryonic process involved in female pregnancy (GO:0060136) | 2.38255712 |
111 | regulation of ARF GTPase activity (GO:0032312) | 2.37410394 |
112 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.36722621 |
113 | regulation of early endosome to late endosome transport (GO:2000641) | 2.36697105 |
114 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.36532316 |
115 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.36215990 |
116 | response to host (GO:0075136) | 2.36215990 |
117 | response to host defenses (GO:0052200) | 2.36215990 |
118 | dendritic cell differentiation (GO:0097028) | 2.35103102 |
119 | response to nerve growth factor (GO:1990089) | 2.34884277 |
120 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.34884277 |
121 | myeloid cell activation involved in immune response (GO:0002275) | 2.34303477 |
122 | negative regulation of interleukin-17 production (GO:0032700) | 2.34231240 |
123 | T cell migration (GO:0072678) | 2.34108907 |
124 | cellular response to biotic stimulus (GO:0071216) | 2.33486095 |
125 | cellular response to growth hormone stimulus (GO:0071378) | 2.31518715 |
126 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.31413755 |
127 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.29336217 |
128 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.27231662 |
129 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.25583949 |
130 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.25326792 |
131 | sexual reproduction (GO:0019953) | 2.23625198 |
132 | nerve growth factor signaling pathway (GO:0038180) | 2.21890199 |
133 | natural killer cell differentiation (GO:0001779) | 2.21743817 |
134 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.21024844 |
135 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.20542113 |
136 | negative regulation of cell size (GO:0045792) | 2.19752845 |
137 | locomotory exploration behavior (GO:0035641) | 2.19536859 |
138 | receptor catabolic process (GO:0032801) | 2.18575194 |
139 | positive regulation of interferon-beta production (GO:0032728) | 2.18521545 |
140 | positive regulation of macrophage cytokine production (GO:0060907) | 2.15789097 |
141 | cellular response to interferon-alpha (GO:0035457) | 2.12122155 |
142 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.11081296 |
143 | regulation of p38MAPK cascade (GO:1900744) | 2.09766457 |
144 | response to type I interferon (GO:0034340) | 2.09604240 |
145 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.09456536 |
146 | cortical actin cytoskeleton organization (GO:0030866) | 2.09045044 |
147 | regulation of gamma-delta T cell activation (GO:0046643) | 2.08591413 |
148 | signal complex assembly (GO:0007172) | 2.07516374 |
149 | negative regulation of lipid transport (GO:0032369) | 2.07046308 |
150 | peptidyl-threonine modification (GO:0018210) | 2.05941612 |
151 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.04267670 |
152 | cellular response to type I interferon (GO:0071357) | 2.02733106 |
153 | type I interferon signaling pathway (GO:0060337) | 2.02733106 |
154 | clathrin coat assembly (GO:0048268) | 2.02395315 |
155 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.02381087 |
156 | establishment of protein localization to Golgi (GO:0072600) | 2.02057451 |
157 | pre-miRNA processing (GO:0031054) | 2.01703580 |
158 | positive regulation of lipid storage (GO:0010884) | 2.01140854 |
159 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.00782041 |
160 | natural killer cell mediated immunity (GO:0002228) | 2.00655774 |
161 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.00655774 |
162 | peptidyl-lysine dimethylation (GO:0018027) | 2.00314544 |
163 | endocytic recycling (GO:0032456) | 1.99570814 |
164 | phospholipid homeostasis (GO:0055091) | 1.99320887 |
165 | plasma membrane repair (GO:0001778) | 1.98826279 |
166 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 1.97352253 |
167 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.96447879 |
168 | peptidyl-threonine phosphorylation (GO:0018107) | 1.96421227 |
169 | positive regulation of lipid catabolic process (GO:0050996) | 1.95856630 |
170 | alanine transport (GO:0032328) | 1.95702291 |
171 | immunoglobulin mediated immune response (GO:0016064) | 1.95516021 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.87018933 |
2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.08226503 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.05010464 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98329384 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.67418923 |
6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.58590721 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.33843423 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.31099478 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23906347 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20913185 |
11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.11167214 |
12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.09126007 |
13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08763403 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.03077728 |
15 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.02401997 |
16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00604253 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98163229 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97065793 |
19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90892089 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87357117 |
21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79728618 |
22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78792814 |
23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74874652 |
24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.72891982 |
25 | KDM2B_26808549_Chip-Seq_K562_Human | 1.71755732 |
26 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70025076 |
27 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.68339337 |
28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67091122 |
29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.63876924 |
30 | MYC_22102868_ChIP-Seq_BL_Human | 1.61011089 |
31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56750730 |
32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55830557 |
33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.55439453 |
34 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50841599 |
35 | MYB_26560356_Chip-Seq_TH2_Human | 1.49993746 |
36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47520301 |
37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.47181011 |
38 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.45411756 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44728958 |
40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44068690 |
41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44045163 |
42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43778219 |
43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42435261 |
44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40460393 |
45 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.40405388 |
46 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39214162 |
47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.37504714 |
48 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37313801 |
49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37230072 |
50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36945811 |
51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36798102 |
52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36151692 |
53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35086247 |
54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33711120 |
55 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.32552221 |
56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.31102697 |
57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28520200 |
58 | MYB_26560356_Chip-Seq_TH1_Human | 1.27241879 |
59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25601242 |
60 | * MAF_26560356_Chip-Seq_TH1_Human | 1.25199037 |
61 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24303151 |
62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23480253 |
63 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22632199 |
64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21588586 |
65 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21333071 |
66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21333071 |
67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20428519 |
68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20081519 |
69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19702921 |
70 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19697891 |
71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19689996 |
72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19112392 |
73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18108128 |
74 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17955338 |
75 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17465048 |
76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16252741 |
77 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15659844 |
78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14867665 |
79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14323172 |
80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13156885 |
81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13119704 |
82 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.13026544 |
83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12022077 |
84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11842995 |
85 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11324022 |
86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10796627 |
87 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.10668904 |
88 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.10668904 |
89 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.10668904 |
90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09953626 |
91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08599235 |
92 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07830208 |
93 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07688056 |
94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07667202 |
95 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.06225740 |
96 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05728652 |
97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05609532 |
98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04328749 |
99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04144474 |
100 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04083010 |
101 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03627060 |
102 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03346470 |
103 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02695043 |
104 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02619098 |
105 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.02166310 |
106 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02093670 |
107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02007835 |
108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00889209 |
109 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00793658 |
110 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00675737 |
111 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00282408 |
112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99882743 |
113 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.99513634 |
114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98635725 |
115 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98531812 |
116 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97219242 |
117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95702510 |
118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95415984 |
119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95221686 |
120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94864975 |
121 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94694182 |
122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94465432 |
123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94422612 |
124 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94309897 |
125 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93786499 |
126 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93756567 |
127 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.92015248 |
128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91552394 |
129 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90797372 |
130 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90141607 |
131 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90140216 |
132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89427466 |
133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88325052 |
134 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87900355 |
135 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87277249 |
136 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86922506 |
137 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86485924 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 3.78443816 |
2 | MP0003705_abnormal_hypodermis_morpholog | 3.52210774 |
3 | MP0003656_abnormal_erythrocyte_physiolo | 3.15188807 |
4 | MP0000569_abnormal_digit_pigmentation | 3.10268870 |
5 | MP0004510_myositis | 3.06987807 |
6 | MP0003300_gastrointestinal_ulcer | 3.04257544 |
7 | MP0010234_abnormal_vibrissa_follicle | 2.91558150 |
8 | MP0005451_abnormal_body_composition | 2.85058865 |
9 | MP0005360_urolithiasis | 2.57444134 |
10 | MP0010352_gastrointestinal_tract_polyps | 2.49562040 |
11 | MP0003724_increased_susceptibility_to | 2.39766133 |
12 | MP0005076_abnormal_cell_differentiation | 2.36119937 |
13 | MP0004859_abnormal_synaptic_plasticity | 2.34536736 |
14 | MP0004858_abnormal_nervous_system | 2.25981406 |
15 | MP0009840_abnormal_foam_cell | 2.22799397 |
16 | MP0003252_abnormal_bile_duct | 2.05458738 |
17 | MP0008961_abnormal_basal_metabolism | 2.04456188 |
18 | MP0005167_abnormal_blood-brain_barrier | 2.02008124 |
19 | MP0003436_decreased_susceptibility_to | 2.00896952 |
20 | MP0003075_altered_response_to | 1.93223381 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.91756019 |
22 | MP0008260_abnormal_autophagy | 1.91414456 |
23 | MP0008004_abnormal_stomach_pH | 1.85492506 |
24 | MP0006082_CNS_inflammation | 1.84611124 |
25 | MP0001835_abnormal_antigen_presentation | 1.83898620 |
26 | MP0004947_skin_inflammation | 1.80330054 |
27 | MP0005058_abnormal_lysosome_morphology | 1.77688514 |
28 | MP0003191_abnormal_cellular_cholesterol | 1.71425776 |
29 | MP0002139_abnormal_hepatobiliary_system | 1.71160495 |
30 | MP0002877_abnormal_melanocyte_morpholog | 1.66553028 |
31 | MP0003045_fibrosis | 1.64708195 |
32 | MP0002332_abnormal_exercise_endurance | 1.61313008 |
33 | MP0003172_abnormal_lysosome_physiology | 1.60969260 |
34 | MP0000604_amyloidosis | 1.60624830 |
35 | MP0003566_abnormal_cell_adhesion | 1.59928350 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.57226297 |
37 | MP0001545_abnormal_hematopoietic_system | 1.57226297 |
38 | MP0001853_heart_inflammation | 1.55233436 |
39 | MP0000343_altered_response_to | 1.53665907 |
40 | MP0005387_immune_system_phenotype | 1.53623398 |
41 | MP0001790_abnormal_immune_system | 1.53623398 |
42 | MP0000858_altered_metastatic_potential | 1.48002740 |
43 | MP0005166_decreased_susceptibility_to | 1.46428044 |
44 | MP0003091_abnormal_cell_migration | 1.45989396 |
45 | MP0004130_abnormal_muscle_cell | 1.45901425 |
46 | MP0000685_abnormal_immune_system | 1.44316357 |
47 | MP0010307_abnormal_tumor_latency | 1.40283495 |
48 | MP0002254_reproductive_system_inflammat | 1.39630530 |
49 | MP0004185_abnormal_adipocyte_glucose | 1.38695798 |
50 | MP0004808_abnormal_hematopoietic_stem | 1.38691242 |
51 | MP0005000_abnormal_immune_tolerance | 1.36202372 |
52 | MP0009278_abnormal_bone_marrow | 1.35840859 |
53 | MP0009780_abnormal_chondrocyte_physiolo | 1.34004842 |
54 | MP0003828_pulmonary_edema | 1.33184250 |
55 | MP0010329_abnormal_lipoprotein_level | 1.30837753 |
56 | MP0002398_abnormal_bone_marrow | 1.24845282 |
57 | MP0005085_abnormal_gallbladder_physiolo | 1.24842445 |
58 | MP0002419_abnormal_innate_immunity | 1.24784655 |
59 | MP0002998_abnormal_bone_remodeling | 1.24544643 |
60 | MP0003763_abnormal_thymus_physiology | 1.24341540 |
61 | MP0003183_abnormal_peptide_metabolism | 1.23666143 |
62 | MP0005464_abnormal_platelet_physiology | 1.23565127 |
63 | MP0002909_abnormal_adrenal_gland | 1.23450713 |
64 | MP0002452_abnormal_antigen_presenting | 1.22384686 |
65 | MP0001800_abnormal_humoral_immune | 1.20274302 |
66 | MP0006054_spinal_hemorrhage | 1.20046254 |
67 | MP0009333_abnormal_splenocyte_physiolog | 1.19198484 |
68 | MP0000609_abnormal_liver_physiology | 1.15686972 |
69 | MP0010155_abnormal_intestine_physiology | 1.13431030 |
70 | MP0001533_abnormal_skeleton_physiology | 1.10808624 |
71 | MP0002723_abnormal_immune_serum | 1.09607690 |
72 | MP0002166_altered_tumor_susceptibility | 1.07828076 |
73 | MP0005025_abnormal_response_to | 1.06738563 |
74 | MP0005164_abnormal_response_to | 1.05910101 |
75 | MP0005365_abnormal_bile_salt | 1.05733629 |
76 | MP0001845_abnormal_inflammatory_respons | 1.05582124 |
77 | MP0009785_altered_susceptibility_to | 1.04902368 |
78 | MP0005310_abnormal_salivary_gland | 1.04886523 |
79 | MP0001849_ear_inflammation | 1.00909990 |
80 | MP0001666_abnormal_nutrient_absorption | 1.00169977 |
81 | MP0002006_tumorigenesis | 0.99381236 |
82 | MP0002429_abnormal_blood_cell | 0.98769364 |
83 | MP0001851_eye_inflammation | 0.98016536 |
84 | MP0002090_abnormal_vision | 0.97595276 |
85 | MP0005623_abnormal_meninges_morphology | 0.97174223 |
86 | MP0000689_abnormal_spleen_morphology | 0.96788771 |
87 | MP0008057_abnormal_DNA_replication | 0.95833750 |
88 | MP0009764_decreased_sensitivity_to | 0.95277955 |
89 | MP0002722_abnormal_immune_system | 0.94702370 |
90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94528164 |
91 | MP0001819_abnormal_immune_cell | 0.92858517 |
92 | MP0005666_abnormal_adipose_tissue | 0.92497466 |
93 | MP0008469_abnormal_protein_level | 0.91597436 |
94 | MP0002420_abnormal_adaptive_immunity | 0.88311176 |
95 | MP0009763_increased_sensitivity_to | 0.87277973 |
96 | MP0004019_abnormal_vitamin_homeostasis | 0.86129098 |
97 | MP0003453_abnormal_keratinocyte_physiol | 0.86095970 |
98 | MP0003448_altered_tumor_morphology | 0.85723276 |
99 | MP0003866_abnormal_defecation | 0.84340000 |
100 | MP0009765_abnormal_xenobiotic_induced | 0.83320296 |
101 | MP0002136_abnormal_kidney_physiology | 0.83152779 |
102 | MP0005375_adipose_tissue_phenotype | 0.80317771 |
103 | MP0003283_abnormal_digestive_organ | 0.80291979 |
104 | MP0003329_amyloid_beta_deposits | 0.79830590 |
105 | MP0003950_abnormal_plasma_membrane | 0.79520395 |
106 | MP0003690_abnormal_glial_cell | 0.79171238 |
107 | MP0001501_abnormal_sleep_pattern | 0.78876062 |
108 | MP0005319_abnormal_enzyme/_coenzyme | 0.78128840 |
109 | MP0000465_gastrointestinal_hemorrhage | 0.77619275 |
110 | MP0002148_abnormal_hypersensitivity_rea | 0.75784643 |
111 | MP0005621_abnormal_cell_physiology | 0.75646246 |
112 | MP0000733_abnormal_muscle_development | 0.75575934 |
113 | MP0000249_abnormal_blood_vessel | 0.75144327 |
114 | MP0004883_abnormal_blood_vessel | 0.75022912 |
115 | MP0000920_abnormal_myelination | 0.74257069 |
116 | MP0002928_abnormal_bile_duct | 0.74031573 |
117 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73795239 |
118 | MP0001348_abnormal_lacrimal_gland | 0.73671443 |
119 | MP0005671_abnormal_response_to | 0.73305101 |
120 | MP0002118_abnormal_lipid_homeostasis | 0.73211918 |
121 | MP0008874_decreased_physiological_sensi | 0.71545302 |
122 | MP0005165_increased_susceptibility_to | 0.69752414 |
123 | MP0005535_abnormal_body_temperature | 0.69725901 |
124 | MP0003633_abnormal_nervous_system | 0.67935385 |
125 | MP0009643_abnormal_urine_homeostasis | 0.67820524 |
126 | MP0005023_abnormal_wound_healing | 0.66815550 |
127 | MP0000371_diluted_coat_color | 0.66122716 |
128 | MP0002405_respiratory_system_inflammati | 0.66091820 |
129 | MP0002896_abnormal_bone_mineralization | 0.65816989 |
130 | MP0002971_abnormal_brown_adipose | 0.65803241 |
131 | MP0000716_abnormal_immune_system | 0.65356252 |
132 | MP0005670_abnormal_white_adipose | 0.64793805 |
133 | MP0002168_other_aberrant_phenotype | 0.64413655 |
134 | MP0001765_abnormal_ion_homeostasis | 0.64179005 |
135 | MP0001915_intracranial_hemorrhage | 0.63453602 |
136 | MP0005409_darkened_coat_color | 0.61853914 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vacuolated lymphocytes (HP:0001922) | 3.07578361 |
2 | Optic neuritis (HP:0100653) | 3.03593364 |
3 | Retrobulbar optic neuritis (HP:0100654) | 3.03593364 |
4 | Neurofibrillary tangles (HP:0002185) | 3.02105125 |
5 | Loss of speech (HP:0002371) | 3.01768415 |
6 | Cerebral aneurysm (HP:0004944) | 2.98957659 |
7 | Pigmentary retinal degeneration (HP:0001146) | 2.92270463 |
8 | Autoimmune thrombocytopenia (HP:0001973) | 2.89481384 |
9 | Hematochezia (HP:0002573) | 2.87971902 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 2.81620756 |
11 | T lymphocytopenia (HP:0005403) | 2.79886440 |
12 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.77726847 |
13 | Myocardial infarction (HP:0001658) | 2.64012070 |
14 | Eczematoid dermatitis (HP:0000976) | 2.63847543 |
15 | Interstitial pulmonary disease (HP:0006530) | 2.60891472 |
16 | Slow saccadic eye movements (HP:0000514) | 2.59918689 |
17 | Frequent falls (HP:0002359) | 2.54821085 |
18 | Systemic lupus erythematosus (HP:0002725) | 2.51392343 |
19 | Hand muscle atrophy (HP:0009130) | 2.50374265 |
20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.49790767 |
21 | Abnormality of T cell number (HP:0011839) | 2.47945055 |
22 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45839297 |
23 | Upper limb amyotrophy (HP:0009129) | 2.45695807 |
24 | Distal upper limb amyotrophy (HP:0007149) | 2.45695807 |
25 | Myositis (HP:0100614) | 2.45469878 |
26 | Spontaneous hematomas (HP:0007420) | 2.40481867 |
27 | Keratoconjunctivitis sicca (HP:0001097) | 2.38611059 |
28 | Autoimmune hemolytic anemia (HP:0001890) | 2.34181264 |
29 | Polycythemia (HP:0001901) | 2.31645039 |
30 | Disinhibition (HP:0000734) | 2.29909520 |
31 | Abnormality of the lower motor neuron (HP:0002366) | 2.28899005 |
32 | Increased cerebral lipofuscin (HP:0011813) | 2.28339219 |
33 | Stomatitis (HP:0010280) | 2.27806296 |
34 | Conjunctival telangiectasia (HP:0000524) | 2.27460681 |
35 | Macroorchidism (HP:0000053) | 2.24566306 |
36 | Thoracolumbar scoliosis (HP:0002944) | 2.22042244 |
37 | Hyperacusis (HP:0010780) | 2.21705829 |
38 | Gastrointestinal infarctions (HP:0005244) | 2.20837302 |
39 | Nuclear cataract (HP:0100018) | 2.20505586 |
40 | Supranuclear gaze palsy (HP:0000605) | 2.20421929 |
41 | Gingival bleeding (HP:0000225) | 2.20294639 |
42 | Abnormality of the Achilles tendon (HP:0005109) | 2.17881062 |
43 | Neuronal loss in central nervous system (HP:0002529) | 2.17740079 |
44 | Achilles tendon contracture (HP:0001771) | 2.16135693 |
45 | Subacute progressive viral hepatitis (HP:0006572) | 2.15923234 |
46 | Striae distensae (HP:0001065) | 2.15393080 |
47 | Mutism (HP:0002300) | 2.14188174 |
48 | Upper motor neuron abnormality (HP:0002127) | 2.11636381 |
49 | Increased serum ferritin (HP:0003281) | 2.11404700 |
50 | Purpura (HP:0000979) | 2.10660668 |
51 | Esophageal varix (HP:0002040) | 2.09202763 |
52 | Deep venous thrombosis (HP:0002625) | 2.08606222 |
53 | Recurrent bacterial skin infections (HP:0005406) | 2.08072661 |
54 | Aneurysm (HP:0002617) | 2.07604082 |
55 | Pulmonary infiltrates (HP:0002113) | 2.07430742 |
56 | Recurrent skin infections (HP:0001581) | 2.05425449 |
57 | Thin bony cortex (HP:0002753) | 2.04394433 |
58 | Epistaxis (HP:0000421) | 2.04120554 |
59 | Keratoconjunctivitis (HP:0001096) | 2.03631565 |
60 | Increased CSF protein (HP:0002922) | 2.01768060 |
61 | Prolonged bleeding time (HP:0003010) | 2.01304051 |
62 | Arterial thrombosis (HP:0004420) | 1.99832992 |
63 | Nephritis (HP:0000123) | 1.99393752 |
64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.98140785 |
65 | Mitral valve prolapse (HP:0001634) | 1.96360031 |
66 | Apathy (HP:0000741) | 1.95380121 |
67 | Retinal atrophy (HP:0001105) | 1.93087659 |
68 | Gastrointestinal stroma tumor (HP:0100723) | 1.92158037 |
69 | Global brain atrophy (HP:0002283) | 1.91778833 |
70 | Poikilocytosis (HP:0004447) | 1.91332567 |
71 | IgA deficiency (HP:0002720) | 1.91064120 |
72 | Enlarged penis (HP:0000040) | 1.90781723 |
73 | Glomerulonephritis (HP:0000099) | 1.90164754 |
74 | Colitis (HP:0002583) | 1.89596810 |
75 | Complement deficiency (HP:0004431) | 1.88162681 |
76 | Aortic aneurysm (HP:0004942) | 1.87556746 |
77 | Gangrene (HP:0100758) | 1.86450968 |
78 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85836667 |
79 | Mucopolysacchariduria (HP:0008155) | 1.85836667 |
80 | Petechiae (HP:0000967) | 1.85523303 |
81 | Lymphangioma (HP:0100764) | 1.83839202 |
82 | Polygenic inheritance (HP:0010982) | 1.82134898 |
83 | Amyloidosis (HP:0011034) | 1.81505866 |
84 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.80041978 |
85 | Bone pain (HP:0002653) | 1.80010011 |
86 | Abnormality of the lumbar spine (HP:0100712) | 1.79632255 |
87 | Heterotopia (HP:0002282) | 1.79284107 |
88 | Recurrent abscess formation (HP:0002722) | 1.79128701 |
89 | Osteomyelitis (HP:0002754) | 1.78939506 |
90 | Axonal loss (HP:0003447) | 1.78804863 |
91 | Congenital stationary night blindness (HP:0007642) | 1.78750262 |
92 | Diminished motivation (HP:0000745) | 1.77300424 |
93 | Dysostosis multiplex (HP:0000943) | 1.77000230 |
94 | Cortical dysplasia (HP:0002539) | 1.76371295 |
95 | Progressive visual loss (HP:0000529) | 1.76239340 |
96 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76119432 |
97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76119432 |
98 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76119432 |
99 | Dysmetric saccades (HP:0000641) | 1.75971160 |
100 | Meningitis (HP:0001287) | 1.75917595 |
101 | Basal ganglia calcification (HP:0002135) | 1.75801852 |
102 | Abnormality of the nasal mucosa (HP:0000433) | 1.75560178 |
103 | Xanthomatosis (HP:0000991) | 1.75413518 |
104 | Resting tremor (HP:0002322) | 1.75341881 |
105 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.75147231 |
106 | Fatigue (HP:0012378) | 1.74883460 |
107 | Thoracic kyphosis (HP:0002942) | 1.74776904 |
108 | Dilatation of the ascending aorta (HP:0005111) | 1.74322285 |
109 | Amaurosis fugax (HP:0100576) | 1.73986343 |
110 | Focal segmental glomerulosclerosis (HP:0000097) | 1.72811697 |
111 | Nasal polyposis (HP:0100582) | 1.72634912 |
112 | Pathologic fracture (HP:0002756) | 1.72149697 |
113 | Peritonitis (HP:0002586) | 1.72142666 |
114 | Abnormality of iron homeostasis (HP:0011031) | 1.72099483 |
115 | Personality changes (HP:0000751) | 1.71539782 |
116 | Inappropriate behavior (HP:0000719) | 1.71459908 |
117 | Abnormality of proline metabolism (HP:0010907) | 1.71316570 |
118 | Hydroxyprolinuria (HP:0003080) | 1.71316570 |
119 | Increased mean platelet volume (HP:0011877) | 1.70070445 |
120 | Tetraparesis (HP:0002273) | 1.69462373 |
121 | Urethral obstruction (HP:0000796) | 1.69345968 |
122 | Bundle branch block (HP:0011710) | 1.69024610 |
123 | Abnormal platelet volume (HP:0011876) | 1.68665899 |
124 | Difficulty climbing stairs (HP:0003551) | 1.68163295 |
125 | Elfin facies (HP:0004428) | 1.67912755 |
126 | Orthostatic hypotension (HP:0001278) | 1.67599943 |
127 | Increased density of long bones (HP:0006392) | 1.67539882 |
128 | Gingivitis (HP:0000230) | 1.67338986 |
129 | Glomerulopathy (HP:0100820) | 1.67195301 |
130 | Recurrent fungal infections (HP:0002841) | 1.67140615 |
131 | Viral hepatitis (HP:0006562) | 1.65541821 |
132 | Urticaria (HP:0001025) | 1.65310651 |
133 | Agnosia (HP:0010524) | 1.65303589 |
134 | Abnormality of the periventricular white matter (HP:0002518) | 1.64986616 |
135 | Papilledema (HP:0001085) | 1.64791583 |
136 | Postural instability (HP:0002172) | 1.64266154 |
137 | Orchitis (HP:0100796) | 1.64095617 |
138 | Action tremor (HP:0002345) | 1.63858647 |
139 | Recurrent viral infections (HP:0004429) | 1.62204703 |
140 | Abnormality of complement system (HP:0005339) | 1.61877350 |
141 | Epidermoid cyst (HP:0200040) | 1.61469260 |
142 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.61414805 |
143 | Asymmetric septal hypertrophy (HP:0001670) | 1.60925340 |
144 | Abnormality of macrophages (HP:0004311) | 1.57403224 |
145 | Vasculitis (HP:0002633) | 1.57058040 |
146 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.57032843 |
147 | Hemorrhage of the eye (HP:0011885) | 1.56330804 |
148 | Long toe (HP:0010511) | 1.55636613 |
149 | Cellulitis (HP:0100658) | 1.55089753 |
150 | Cerebral inclusion bodies (HP:0100314) | 1.54878318 |
151 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.54322501 |
152 | Abnormality of glycolipid metabolism (HP:0010969) | 1.53467848 |
153 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.53467848 |
154 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.53467848 |
155 | Mitral stenosis (HP:0001718) | 1.53158760 |
156 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.52088501 |
157 | Osteolytic defects of the hand bones (HP:0009699) | 1.52088501 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK3 | 4.90020578 |
2 | PRPF4B | 3.87673814 |
3 | TRIB3 | 3.53145410 |
4 | TAOK2 | 2.91554779 |
5 | PKN2 | 2.77623584 |
6 | MAP3K9 | 2.65072009 |
7 | RIPK4 | 2.59556354 |
8 | RIPK1 | 2.58588032 |
9 | MAP3K10 | 2.40277790 |
10 | KSR2 | 2.29546270 |
11 | ERN1 | 2.21116803 |
12 | NME2 | 2.01299149 |
13 | BMPR2 | 1.95994445 |
14 | MAP3K3 | 1.89261999 |
15 | TBK1 | 1.88323766 |
16 | JAK1 | 1.88191559 |
17 | CAMK1D | 1.83478889 |
18 | CAMK1G | 1.82832010 |
19 | EEF2K | 1.81262792 |
20 | TYK2 | 1.78814654 |
21 | CDK12 | 1.76578666 |
22 | IRAK4 | 1.75712614 |
23 | PTK6 | 1.73273745 |
24 | GRK7 | 1.73226761 |
25 | TAOK1 | 1.73109226 |
26 | CAMKK1 | 1.71524984 |
27 | SIK2 | 1.62921428 |
28 | ACVR1B | 1.62578612 |
29 | BLK | 1.61804865 |
30 | MAP3K2 | 1.51421969 |
31 | ALK | 1.49473042 |
32 | BMX | 1.49373421 |
33 | MAP3K14 | 1.49036701 |
34 | SCYL2 | 1.48880403 |
35 | PDGFRA | 1.46311606 |
36 | MAP3K11 | 1.45266743 |
37 | MAP3K13 | 1.39065909 |
38 | PRKD3 | 1.37034704 |
39 | MAP4K1 | 1.36351794 |
40 | RET | 1.35903834 |
41 | MOS | 1.35208537 |
42 | FGFR4 | 1.32806917 |
43 | STK24 | 1.28161549 |
44 | TGFBR2 | 1.21685923 |
45 | CDC42BPA | 1.20353492 |
46 | FGFR3 | 1.19748451 |
47 | IRAK2 | 1.18917868 |
48 | TTN | 1.17662238 |
49 | TESK1 | 1.12230332 |
50 | DAPK2 | 1.10820516 |
51 | JAK2 | 1.06654241 |
52 | IRAK1 | 1.06411815 |
53 | PDK1 | 1.05234759 |
54 | JAK3 | 1.03864433 |
55 | FRK | 1.02736459 |
56 | PAK6 | 1.02486757 |
57 | PDGFRB | 0.96863903 |
58 | PRKCH | 0.95185833 |
59 | PDPK1 | 0.94206650 |
60 | LRRK2 | 0.93560665 |
61 | STK38 | 0.91524002 |
62 | SIK1 | 0.87856708 |
63 | NTRK3 | 0.86938703 |
64 | ICK | 0.85641003 |
65 | MAP3K7 | 0.85328598 |
66 | LMTK2 | 0.84095450 |
67 | HCK | 0.83021810 |
68 | GRK6 | 0.82613472 |
69 | PIM1 | 0.80593262 |
70 | SGK3 | 0.80098446 |
71 | CAMKK2 | 0.79071253 |
72 | PTK2 | 0.77355085 |
73 | CSK | 0.76475599 |
74 | SGK2 | 0.75564015 |
75 | EPHB1 | 0.74560832 |
76 | STK11 | 0.74505944 |
77 | MAP3K1 | 0.73593114 |
78 | MAP3K4 | 0.72230256 |
79 | CDK6 | 0.72120071 |
80 | MTOR | 0.71827746 |
81 | NTRK1 | 0.71598856 |
82 | PDK3 | 0.71259981 |
83 | PDK4 | 0.71259981 |
84 | MARK3 | 0.70544612 |
85 | WNK1 | 0.69416099 |
86 | TRPM7 | 0.69265710 |
87 | TYRO3 | 0.68790271 |
88 | TAOK3 | 0.68694464 |
89 | CLK1 | 0.68468536 |
90 | EGFR | 0.67977288 |
91 | TXK | 0.67342026 |
92 | IKBKE | 0.67190178 |
93 | ZAP70 | 0.66588012 |
94 | KSR1 | 0.66271468 |
95 | MAP2K3 | 0.65664397 |
96 | STK10 | 0.63980663 |
97 | CHUK | 0.62617164 |
98 | BTK | 0.62610100 |
99 | MAP2K4 | 0.62099135 |
100 | LYN | 0.59234330 |
101 | DMPK | 0.59162480 |
102 | YES1 | 0.58856762 |
103 | LATS1 | 0.57901833 |
104 | NEK9 | 0.57587251 |
105 | MAP2K1 | 0.56721949 |
106 | MINK1 | 0.56537544 |
107 | MARK2 | 0.56337971 |
108 | PTK2B | 0.56018827 |
109 | ABL2 | 0.55640999 |
110 | LATS2 | 0.55084975 |
111 | MAP3K5 | 0.54107728 |
112 | STK4 | 0.53514864 |
113 | DDR2 | 0.53031392 |
114 | STK3 | 0.51807300 |
115 | BRD4 | 0.50849433 |
116 | SIK3 | 0.50122478 |
117 | FGR | 0.48424240 |
118 | LCK | 0.48313511 |
119 | PRKG2 | 0.48217637 |
120 | MATK | 0.48205584 |
121 | FGFR1 | 0.47106508 |
122 | MST1R | 0.47099672 |
123 | IKBKB | 0.46538824 |
124 | HIPK2 | 0.45743507 |
125 | CDK4 | 0.45478293 |
126 | PRKCZ | 0.44866194 |
127 | SYK | 0.44419176 |
128 | PIM2 | 0.42857331 |
129 | MAP3K8 | 0.42319922 |
130 | MELK | 0.42253304 |
131 | PAK4 | 0.40301841 |
132 | SGK1 | 0.39379534 |
133 | RPS6KA4 | 0.39243468 |
134 | CSF1R | 0.38898578 |
135 | FYN | 0.38216372 |
136 | DYRK1B | 0.37859915 |
137 | TEC | 0.34812679 |
138 | DYRK3 | 0.33544755 |
139 | MAPK7 | 0.31402498 |
140 | RPS6KL1 | 0.30435950 |
141 | RPS6KC1 | 0.30435950 |
142 | ARAF | 0.30158224 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88690561 |
2 | Malaria_Homo sapiens_hsa05144 | 2.06671174 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.98539583 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 1.95778540 |
5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69770546 |
6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.66475190 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55543410 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 1.55535621 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54487863 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53862765 |
11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.48232102 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.41704827 |
13 | Asthma_Homo sapiens_hsa05310 | 1.39714283 |
14 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.39235845 |
15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38691993 |
16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37683207 |
17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36905994 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34676424 |
19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27796377 |
20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.25895819 |
21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.25535051 |
22 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.24561975 |
23 | Bladder cancer_Homo sapiens_hsa05219 | 1.24442021 |
24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23096678 |
25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21991931 |
26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21244280 |
27 | Phototransduction_Homo sapiens_hsa04744 | 1.20906531 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17010188 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15886304 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15825488 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.15207360 |
32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.14839223 |
33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12927402 |
34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11610348 |
35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09884525 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.09827189 |
37 | Glioma_Homo sapiens_hsa05214 | 1.09589769 |
38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08858087 |
39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06221373 |
40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05153364 |
41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04878450 |
42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04587669 |
43 | Insulin resistance_Homo sapiens_hsa04931 | 0.99604384 |
44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97905435 |
45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97645033 |
46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96663337 |
47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94670600 |
48 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.94055956 |
49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93639995 |
50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93320767 |
51 | Pertussis_Homo sapiens_hsa05133 | 0.92048564 |
52 | Influenza A_Homo sapiens_hsa05164 | 0.91331519 |
53 | Amoebiasis_Homo sapiens_hsa05146 | 0.91119729 |
54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90857641 |
55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90119940 |
56 | Phagosome_Homo sapiens_hsa04145 | 0.89825283 |
57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88299378 |
58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88198069 |
59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87332957 |
60 | Legionellosis_Homo sapiens_hsa05134 | 0.86698677 |
61 | Salmonella infection_Homo sapiens_hsa05132 | 0.86659192 |
62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.85767912 |
63 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85475415 |
64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84966575 |
65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83812334 |
66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83383578 |
67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83137610 |
68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81988617 |
69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80233462 |
70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78863179 |
71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77514744 |
72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76847249 |
73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76226140 |
74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76061706 |
75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75707117 |
76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73666700 |
77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72896067 |
78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72595548 |
79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72237002 |
80 | Mineral absorption_Homo sapiens_hsa04978 | 0.72144483 |
81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71362179 |
82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71118514 |
83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70821290 |
84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70682103 |
85 | Endocytosis_Homo sapiens_hsa04144 | 0.69680687 |
86 | Hepatitis B_Homo sapiens_hsa05161 | 0.69606963 |
87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69541279 |
88 | Apoptosis_Homo sapiens_hsa04210 | 0.68956185 |
89 | Hepatitis C_Homo sapiens_hsa05160 | 0.68130623 |
90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67936685 |
91 | Renin secretion_Homo sapiens_hsa04924 | 0.67471385 |
92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67423127 |
93 | Measles_Homo sapiens_hsa05162 | 0.66514133 |
94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66479890 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.66339733 |
96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66182617 |
97 | Lysosome_Homo sapiens_hsa04142 | 0.66115030 |
98 | Adherens junction_Homo sapiens_hsa04520 | 0.66061434 |
99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65605521 |
100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65581049 |
101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65154919 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64843465 |
103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63668447 |
104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63653365 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63449360 |
106 | Platelet activation_Homo sapiens_hsa04611 | 0.63117279 |
107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62792880 |
108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61670182 |
109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61310171 |
110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60416634 |
111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60052009 |
112 | Shigellosis_Homo sapiens_hsa05131 | 0.59888550 |
113 | Salivary secretion_Homo sapiens_hsa04970 | 0.59111478 |
114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58704253 |
115 | Prion diseases_Homo sapiens_hsa05020 | 0.57722185 |
116 | Insulin secretion_Homo sapiens_hsa04911 | 0.57402776 |
117 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56884295 |
118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56710281 |
119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56198987 |
120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55686492 |
121 | Lysine degradation_Homo sapiens_hsa00310 | 0.54841231 |
122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54092537 |
123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54090211 |
124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53944201 |
125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53926629 |
126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53804255 |
127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53691835 |
128 | Focal adhesion_Homo sapiens_hsa04510 | 0.52766923 |
129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52266279 |
130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49244706 |
131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48077636 |
132 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47871237 |
133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45528942 |
134 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44229543 |
135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42296102 |